Evaluation of Efficacy and Potential Complications of the Plant-Based Nanoparticles Hemostat Powder on Controlling Hemorrhage in Rat Models of Liver Injury: An Experimental Study

Liver resection requires time management due to the high risk of bleeding. Plant-based materials are superior to other agents in  reducing complications during hemostasis. This present study aimed to investigate the effect of plant-based topical hemostatic nanoparticles from the rosaceous as an innovative hemostatic agent.

Twenty male Wistar rats were randomly divided into two study groups. All rats were anesthetized and their anterior lobe of the  liver was amputated. The incision site was directly pressed with a dry gauze for 2 minutes in the control group and repeated every
30 seconds until hemostasis was achieved. Homeostatic material was compressed on the incision site and clotting time was  recorded in the intervention group. The mean hemostasis time was compared in both groups using Paired Samples Test. P <0.05
was considered statistically significant.

Hemostasis was successfully achieved in both groups. The hemostasis time were 6.7±1.33 and 183±26.26 in Nanoparticles and  control groups, respectively and their differences were significant (P<0.001). Histopathology evaluation indicated a slight increase  in vascularity, fibrosis, and polymorphonuclear neutrophil (PMN) infiltration in one case. Mild to moderate lymphocyte  infiltration was detected in 2 cases.

The produced plant-based Nanoparticles could significantly reduce the hemostasis time in the intervention group compared to that  of the control one.